Quanex price target lowered to $28 from $30 at Benchmark

Benchmark lowered the firm’s price target on Quanex (NX) to $28 from $30 and keeps a Buy rating on the shares. While FY26 guidance has been pushed to the company’s Q1 results release, management’s current view is for a flattish year-over-year comparison with the first half likely more challenged than the back half, notes the analyst, who is moving the firm’s FY26 and FY27 EPS estimates lower given the uncertain outlook.